DiaMedica Therapeutics Inc (DMAC)
3.39
-0.31
(-8.38%)
USD |
NASDAQ |
May 08, 14:48
DiaMedica Therapeutics Accounts Payable (Quarterly): 0.926M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.926M |
September 30, 2023 | 0.863M |
June 30, 2023 | 0.856M |
March 31, 2023 | 1.78M |
December 31, 2022 | 0.734M |
September 30, 2022 | 0.864M |
June 30, 2022 | 0.624M |
March 31, 2022 | 0.433M |
December 31, 2021 | 0.509M |
September 30, 2021 | 0.699M |
June 30, 2021 | 0.239M |
March 31, 2021 | 0.689M |
December 31, 2020 | 1.099M |
September 30, 2020 | 0.72M |
June 30, 2020 | 0.552M |
March 31, 2020 | 0.444M |
December 31, 2019 | 0.182M |
September 30, 2019 | 0.312M |
June 30, 2019 | 0.262M |
March 31, 2019 | 0.685M |
December 31, 2018 | 0.483M |
September 30, 2018 | 0.4009M |
June 30, 2018 | 0.5861M |
March 31, 2018 | 0.6369M |
December 31, 2017 | 0.513M |
Date | Value |
---|---|
September 30, 2017 | 0.5254M |
June 30, 2017 | 0.5535M |
March 31, 2017 | 0.5411M |
December 31, 2016 | 0.25M |
September 30, 2016 | 1.051M |
June 30, 2016 | 0.9919M |
March 31, 2016 | 0.5917M |
December 31, 2015 | 0.6741M |
September 30, 2015 | 0.5651M |
June 30, 2015 | 0.2707M |
March 31, 2015 | 0.2472M |
December 31, 2014 | |
September 30, 2014 | 0.3517M |
June 30, 2014 | 0.3756M |
March 31, 2014 | 0.1932M |
December 31, 2013 | 0.3721M |
September 30, 2013 | 0.3182M |
June 30, 2013 | 0.3677M |
March 31, 2013 | 1.241M |
December 31, 2012 | 1.192M |
September 30, 2012 | 0.4493M |
June 30, 2012 | 0.6922M |
March 31, 2012 | |
December 31, 2011 | 0.1391M |
September 30, 2011 | 0.2625M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.182M
Minimum
Dec 2019
1.78M
Maximum
Mar 2023
0.673M
Average
0.689M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
NextCure Inc | 4.491M |
NovaBay Pharmaceuticals Inc | 1.13M |
Palatin Technologies Inc | 1.594M |
iBio Inc | 1.859M |
Theriva Biologics Inc | 0.77M |